Perihilar Cholangiocarcinoma Clinical Trial
Official title:
A Combined Endoscopy and Radiology-guided Radiofrequency Ablation Therapy Protocol for Inoperable Perihilar Cholangiocarcinoma
This prospective clinical trial aims to assess the feasibility, efficacy, and safety of a personalized radiofrequency ablation protocol coupled with complete biliary drainage for patients presenting with inoperable perihilar cholangiocarcinoma.
This clinical trial proposes a personalized treatment approach to inoperable perihilar cholangiocarcinoma consisting of endoluminal ablative therapy via radiofrequency ablation followed by endoscopic biliary drainage. Patients presenting with jaundice / biliary obstruction caused by inoperable perihilar cholangiocarcinoma as assessed during multidisciplinary case discussion will be invited to enroll in this trial. Patients will be randomized in a 1:1 fashion to receive biliary plastic stenting (control arm) or biliary plastic stenting + radiofrequency ablation via endoscopic approach. In cases where ERCP fails to achieve adequate biliary drainage, stenting and/or drainage will be attempted via percutaneous approach. Additional systemic chemotherapy will be offered to all eligible patients according to the local standard of care. Patients will be followed up with a clinical visit at 2 weeks and stent exchange (+ additional RFA treatment in the control arm) will be offered at 8-12 weeks interval until disease progression, clinical deterioration precluding ERCP or death. The main study objectives are: - To assess the technical feasibility of implementing the proposed therapeutic protocol involving a combined endoscopic-radiologic approach to drainage and ablation - To evaluate the efficacy of radiofrequency ablation in local disease control - To evaluate whether complete drainage and radiofrequency ablation have a cumulative benefit in patients with inoperable perihilar cholangiocarcinoma - To evaluate the safety of our proposed therapeutic protocol combining interventional endoscopy with radiology ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04993131 -
Liver Transplantation for Non-resectable Perihilar Cholangiocarcinoma
|
N/A | |
Recruiting |
NCT05546372 -
Endobiliary Radiofrequency Ablation for Malignant Biliary Obstruction Due to Perihilar Cholangiocarcinoma
|
N/A | |
Recruiting |
NCT05024513 -
Biliary Drainage Plus HAIC in Locally Advanced pCCA
|
Phase 2 | |
Completed |
NCT05402618 -
Minimally Invasive Versus Open Surgery for PHC
|
||
Recruiting |
NCT05874934 -
Endoscopic Drainage of Presumed Resectable pCCA Using an Intrahepatic Plastic Stent With Retrieval String
|
N/A | |
Recruiting |
NCT04561453 -
Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
|
||
Active, not recruiting |
NCT05078801 -
Endoscopic Versus Radiologic Biliary Drainage for Perihilar Malignant Obstruction
|
||
Recruiting |
NCT05430698 -
PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma
|
Phase 2 | |
Recruiting |
NCT06125769 -
LIver TrAnspLantation for Non-resectable Peri-HIlar cholangioCArcinoma (LITALHICA)
|
N/A | |
Recruiting |
NCT04846192 -
Prognosis of Nutritional Status for Surgical Peri Hilar Cholangiocarcinoma
|
||
Completed |
NCT06357117 -
Extent of Intrahepatic Infiltration of Perihilar Cholangiocarcinoma
|